lanosterol demethylase inhibitors (University of Washington/CPDD)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namelanosterol demethylase inhibitors (University of Washington/CPDD)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Consortium for Parasitic Drug DevelopmentUniversity Of Washington
Active IndicationsN/A
Inactive IndicationsLeishmaniasis

Other Information

ATC CodeN/A
Related LinksN/A